Relay Therapeutics, Inc.
US ˙ NasdaqGM ˙ US75943R1023

SecurityRLAY / Relay Therapeutics, Inc.
InstitutionCitigroup Inc
Latest Disclosed Ownership29,754 shares
Latest Disclosed Value $ 296,052
Citigroup Inc reports 3.80% decrease in ownership of RLAY / Relay Therapeutics, Inc.

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 29,754 shares of Relay Therapeutics, Inc. (US:RLAY) valued at $296,052 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 30,930 shares of Relay Therapeutics, Inc.. This represents a change in shares of -3.80% during the quarter. The current value of the position is $455,236 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F RELAY THERAPEUTICS COM 75943R102 29,754 -1,176 -3.80 296 13.41 0.0001
2026-02-13 2025-12-31 13F RELAY THERAPEUTICS COM 75943R102 30,930 16,616 116.08 262 252.70 0.0001
2025-11-10 2025-09-30 13F RELAY THERAPEUTICS COM 75943R102 14,314 -109,079 -88.40 75 -82.63 0.0000
2025-08-11 2025-06-30 13F RELAY THERAPEUTICS COM 75943R102 123,393 -136,920 -52.60 427 -37.54 0.0002
2025-05-12 2025-03-31 13F RELAY THERAPEUTICS COM 75943R102 260,313 54,637 26.56 682 -19.48 0.0003
2025-02-12 2024-12-31 13F RELAY THERAPEUTICS COM 75943R102 205,676 118,290 135.36 847 37.06 0.0005
2024-11-12 2024-09-30 13F RELAY THERAPEUTICS COM 75943R102 87,386 43,796 100.47 619 117.61 0.0004
2024-08-12 2024-06-30 13F RELAY THERAPEUTICS COM 75943R102 43,590 -371,387 -89.50 284 -91.75 0.0002
2024-05-10 2024-03-31 13F RELAY THERAPEUTICS COM 75943R102 414,977 268,714 183.72 3,444 113.91 0.0023
2024-02-09 2023-12-31 13F RELAY THERAPEUTICS COM 75943R102 146,263 -24,821 -14.51 1,610 11.96 0.0011
2023-12-06 2023-09-30 13F/A-1 RELAY THERAPEUTICS COM 75943R102 171,084 -30,622 -15.18 1,439 -43.23 0.0011
2023-11-09 2023-09-30 13F RELAY THERAPEUTICS COM 75943R102 171,084 -30,622 1,439 0.0004
2023-08-10 2023-06-30 13F RELAY THERAPEUTICS COM 75943R102 201,706 -154,406 -43.36 2,533 -56.81 0.0017
2023-05-11 2023-03-31 13F RELAY THERAPEUTICS COM 75943R102 356,112 146,872 70.19 5,865 87.62 0.0041
2023-02-09 2022-12-31 13F RELAY THERAPEUTICS COM 75943R102 209,240 27,462 15.11 3,126 -23.12 0.0025
2022-11-10 2022-09-30 13F RELAY THERAPEUTICS COM 75943R102 181,778 -4,380 -2.35 4,066 30.40 0.0029
2022-08-10 2022-06-30 13F RELAY THERAPEUTICS COM 75943R102 186,158 154,898 495.52 3,118 233.12 0.0023
2022-05-12 2022-03-31 13F RELAY THERAPEUTICS COM 75943R102 31,260 -128,355 -80.42 936 -80.91 0.0006
2022-02-10 2021-12-31 13F RELAY THERAPEUTICS COM 75943R102 159,615 25,382 18.91 4,902 15.83 0.0026
2021-11-10 2021-09-30 13F RELAY THERAPEUTICS COM 75943R102 134,233 11,007 8.93 4,232 -6.14 0.0025
2021-08-10 2021-06-30 13F RELAY THERAPEUTICS COM 75943R102 123,226 15,312 14.19 4,509 20.85 0.0027
2021-05-13 2021-03-31 13F RELAY THERAPEUTICS COM 75943R102 107,914 98,096 999.14 3,731 814.46 0.0024
2021-02-11 2020-12-31 13F RELAY THERAPEUTICS COM 75943R102 9,818 8,272 535.06 408 518.18 0.0002
2020-11-12 2020-09-30 13F RELAY THERAPEUTICS COM 75943R102 1,546 1,546 66 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.